ANGELALIGN (06699) issued 123,800 restricted share units and 300,000 share purchase rights.
Epoch Angel (06699) announced that, in order to provide long-term incentives to key employees, on March 30, 2026 (the Restricted Share Unit Grant Date), the company granted 123,800 restricted share units (RSUs) to 51 grantees (restricted share unit grantees) under the company's Restricted Share Unit Plan after the company's initial public offering. This is equivalent to a total of 123,800 shares of the company's common stock (shares) granted as restricted share units.
ANGELALIGN (06699) announced that in order to provide long-term incentives to key employees, on March 30, 2026 (restricted share unit grant date), the Company granted 123,800 restricted share units (RSUs) to 51 grantees (restricted share unit grantees) under the Company's Restricted Share Unit Plan following the Company's initial public offering, equivalent to a total of 123,800 ordinary shares of the Company (RSUs granted).
Furthermore, to provide long-term incentives to key employees, on March 30, 2026 (stock option grant date), the Company granted 300,000 stock options to one grantee (stock option grantee, together with restricted share unit grantees, collectively referred to as "grantees"), giving the grantee the right to subscribe for a total of 300,000 shares of the Company's ordinary shares after exercising those stock options under the Company's Stock Option Plan following the Company's initial public offering (stock options granted).
Related Articles

RENRUI HR (06919) released its annual performance report, with a net profit attributable to shareholders of 87.55 million yuan, turning a loss into a profit compared to the previous year.

BOAN BIOTECH (06955) announced its annual performance, with a net profit attributable to shareholders of 7.144 million yuan, a year-on-year decrease of 90.24%.

RUNHUA SERVICE (02455) announced its 2025 annual performance, with a net profit attributable to shareholders of RMB 46.32 million, an increase of 1.7% year-on-year.
RENRUI HR (06919) released its annual performance report, with a net profit attributable to shareholders of 87.55 million yuan, turning a loss into a profit compared to the previous year.

BOAN BIOTECH (06955) announced its annual performance, with a net profit attributable to shareholders of 7.144 million yuan, a year-on-year decrease of 90.24%.

RUNHUA SERVICE (02455) announced its 2025 annual performance, with a net profit attributable to shareholders of RMB 46.32 million, an increase of 1.7% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


